Surmount · investment strategy
by Quantbase · via Surmount
Invests in 29 leading companies advancing artificial intelligence across tech, healthcare, biotech, and more. Rebalanced quarterly, this strategy targets long-term growth by capturing the transformative impact of AI across industries.
Description from Surmount
of the return and risk figures:as the source publishes them
What $10,000 would have become, from the strategy's own published history, against the S&P 500 over the same dates. The basis is labelled.
Each rule is quoted word for word from the strategy's own documents.
“Invests in 29 leading companies advancing artificial intelligence across tech, healthcare, biotech, and more.”
“Rebalanced quarterly”
28 positions as of 2026-10-20
by the source.
Top 25 of 28 shown.
Fitted to 120 returns (model) from 2025-11-05 to 2026-10-19. An estimate, not holdings: it can't name stocks.
· : 0.48 · Too loose a fit for a verdict; shown as a guide.
Beta to the S&P 500: 1.05 (90%: 0.80 to 1.21)
Compares the stated rules with the holdings (or, where none are published, a mix estimated from returns), using tests fixed before any results were seen.
0.0% of weight in (IVV: 3.0%)
2 funds (SEC N-PORT, as of 2026-07-31)
No stated fossil-fuel rule; the exposure is shown for reference. : 100% · 2026-10-20
0.0% of weight in (SPY: 0%)
Fewer than 70% of the holdings could be identified, so there’s no verdict. : 35% · 2026-10-20
How much of what we look for this strategy has, and why anything is missing. Fields that don't apply to it aren't counted.
1 missing
Rebalance schedule taken from a stated rule.
The text the rules are quoted from, with where it came from.
Invests in 29 leading companies advancing artificial intelligence across tech, healthcare, biotech, and more. Rebalanced quarterly, this strategy targets long-term growth by capturing the transformative impact of AI across industries.
Meticulously invests in AI companies across various sectors with strategic rebalancing techniques
Invests in 29 leading companies advancing artificial intelligence across tech, healthcare, biotech, and more. Rebalanced quarterly, this strategy targets long-term growth by capturing the transformative impact of AI across industries.
Every value on file, each labelled with its calculation basis and as-of date.
| Asset classes / instruments | equity | 2026-10-20 |
| Minimum investment | $100 | 2026-10-20 |
| Industry weights (Surmount) | Healthcare: 96.7% · Financial Services: 3.3% | 2026-10-20 |
| Investors following (Surmount) | 12 | 2026-10-20 |
| Annual return (Surmount tracking) (model tracking) | 0.95% | ||
| Return, 1 year (Surmount tracking) (model tracking) | 39.58% | 2026-10-20 | |
| Return, 3 months (Surmount tracking) (model tracking) | 17.30% | 2026-10-20 | |
| Return, year to date (Surmount tracking) (model tracking) | 34.63% | 2026-10-20 | |
| Total return (Surmount tracking) (model tracking) | 4.84% |
| Maximum drawdown (Surmount tracking) (model tracking) | -47.06% |
| Risk score (Surmount) | 3.39 | 2026-10-20 |
